Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Open-market sale Director sold 3,400 shares at $66.82 ($227,188)
  2. 4 Option exercise Chief Executive Officer acquired 11,806 shares (option exercise)
  3. 4 Open-market sale Chief Executive Officer sold 60,000 shares at an average $67.56 ($4,053,431)
  4. 4 Open-market sale Chief Medical Officer sold 19,500 shares at an average $69.31 ($1,351,589)
  5. 4 Open-market sale Chief Executive Officer sold 65,000 shares at an average $65.77 ($4,274,982)
  6. 4 Open-market sale Director sold 5,000 shares at $63.76 ($318,800)
  7. 4 Open-market sale Director sold 5,000 shares at $65.24 ($326,200)
  8. 4 Open-market sale Director sold 5,000 shares at $89.85 ($449,250)
  9. 4 Open-market sale Chief Commercial Officer sold 3,625 shares at $89.22 ($323,423)
  10. 4 Open-market sale Director sold 4,500 shares at $89.21 ($401,445)
  11. 4 Open-market sale Director sold 1,125 shares at $88.73 ($99,821)
  12. 4 Open-market sale General Counsel sold 90,000 shares at an average $88.46 ($7,961,240)
  13. 4 Open-market sale Director sold 3,000 shares at $83.28 ($249,840)
  14. 4 Open-market sale Senior Vice President sold 10,000 shares at an average $81.29 ($812,942)
  15. 4 Open-market sale Chief Financial Officer sold 13,038 shares at an average $81.02 ($1,056,310)
  16. 4 Open-market sale Chief Commercial Officer sold 15,625 shares at $75.00 ($1,171,875)
  17. 4 Open-market sale General Counsel sold 25,000 shares at an average $72.41 ($1,810,346)
  18. 4 Open-market sale Chief Financial Officer sold 30,625 shares at an average $72.44 ($2,218,477)
  19. 4 Open-market sale Senior Vice President sold 38,750 shares at an average $72.51 ($2,809,578)
  20. 4 Grant or award General Counsel acquired 60,000 shares (grant or award)

Page 8 of 25 · 497 filings